TY  - GEN
AU  - Lee,Sang Eun
AU  - Kim,Yong-Jin
AU  - Lee,Hae-Young
AU  - Yang,Han-Mo
AU  - Park,Chang-Gyu
AU  - Kim,Jae-Joong
AU  - Kim,Soon-Kil
AU  - Rhee,Moo-Yong
AU  - Oh,Byung-Hee
TI  - Efficacy and tolerability of fimasartan, a new angiotensin receptor blocker, compared with losartan (50/100 mg): a 12-week, phase III, multicenter, prospective, randomized, double-blind, parallel-group, dose escalation clinical trial with an optional 12-week extension phase in adult Korean patients with mild-to-moderate hypertension
SN  - 1879-114X
PY  - 2012///0716
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Angiotensin Receptor Antagonists
KW  - administration & dosage
KW  - Antihypertensive Agents
KW  - Biphenyl Compounds
KW  - adverse effects
KW  - Blood Pressure
KW  - drug effects
KW  - Dose-Response Relationship, Drug
KW  - Double-Blind Method
KW  - Female
KW  - Humans
KW  - Hypertension
KW  - diagnosis
KW  - Losartan
KW  - Male
KW  - Middle Aged
KW  - Prospective Studies
KW  - Pyrimidines
KW  - Republic of Korea
KW  - Severity of Illness Index
KW  - Tetrazoles
KW  - Treatment Outcome
KW  - Young Adult
N1  - Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.clinthera.2012.01.024
ER  -